About Galen Partners
Galen Partners is a private equity firm founded in 1990. It is primarily based in Stamford, United States. As of Oct 2026, Galen Partners has a portfolio of 49 companies, comprising 49 funding rounds and 3 acquisitions. The firm primarily invests in companies based in United States and Israel. Its portfolio is spread across a wide range of sectors from Life Sciences to HealthTech. Most recently it acquired stakes in Evolve Treatment Centers on Jan 08, 2020.
Overall Galen Partners portfolio has seen 6 IPOs and 28 acquisitions, namely Sharecare, Tactile Medical and Life Image. A lot of funds co-invest with Galen Partners, with names like Tomorrow Ventures sharing a substantial percentage of its portfolio.
Galen Partners has a team of 14 people, including 13 partners.
Key Metrics
Founded Year
1990
Location
Stamford, United States
Portfolio Companies
Portfolio Sectors
Portfolio Locations
Acquisition Deals
Investment Deals
Galen Partners' Portfolio
Galen Partners has a portfolio of 49 companies. They have invested in a total of 49 companies. Their most recent investment was in PeriGen (Series B round) on Sep 27, 2016. Here are the most recent investments by Galen Partners:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Sep 27, 2016 | Series B | 6818 | ||
Apr 11, 2016 | Series C | 2393 | ||
Jun 09, 2015 | Series C | 5485 | and 5 others | |
Apr 18, 2013 | Series C | 7241 | - |
Galen Partners has acquired 3 companies. Their most recent acquisition was of Evolve Treatment Centers on Jan 08, 2020. Here are the most recent acquisitions by Galen Partners:
Acquisition Date | Company | Short Description | Total Funding | Founded Year |
|---|---|---|---|---|
Jan 08, 2020 | Provider of mental health treatment and behavioral health care services for adolescents | - | 2014 | |
Jul 19, 2018 | Provider of karaoke, restaurant, and nightlife services | - | 2003 | |
Jul 11, 2017 | Provider of AI-based platform to detect precancerous tissues | $16M | 1997 |
Here is the portfolio snapshot of Galen Partners:
Acquisitions by Year
The maximum number of acquisitions were made in 2020
Portfolio by Location
Companies are primarily in United States and Israel
Portfolio by Sector
Companies are primarily in Life Sciences
Team profile of Galen Partners
Galen Partners has a team of 14 members including 13 Partners and 1 Venture Partner located in United States. Galen Partners' team does not sit on the board of any company as of now.Here is a list of top team members in Galen Partners:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | New York City | - | ||
Partner | Stamford | - | ||
Partner | Irving | - | - | |
Partner | New York City | - | - | |
Partner | Nashville | - | - | |
Partner | New York City | - | ||
Partner | Omaha | - | ||
Partner | Potwin | - | ||
Partner | Princeton | - | - | |
Partner | - | - | - | |
Partner | Washington | - | - |
Co-investors of Galen Partners
Over the past 36 years, 14 investors have co-invested in Galen Partners's portfolio companies.
- Top Co-investors of Galen Partners: 14 investors entered a company along with Galen Partners. These include investors like Tomorrow Ventures (1 company).
Galen Partners News
•
Ex-CCO of InTouch Health to Join Galen as Special Investment PartnerPR Newswire•Sep 09, 2020•Galen Partners, InTouch Technologies
•
Ex-CCO of InTouch Health to Join Galen as Special Investment PartnerNewswire•Sep 09, 2020•InTouch Technologies, Galen Partners
•
Galen Partners completes acquisition of Evolve Treatment Centers, a leading provider of adolescent behavioral health services in CaliforniaGlobeNewswire•Jan 08, 2020•Galen Partners, Evolve Treatment Centers
•
Galen Partners completes add-on acquisition for SMP Pharmacy Solutions, a niche-focused, high-touch specialty pharmacyGlobeNewswire•Oct 24, 2019•Galen Partners, SMP
•
•
SMP Pharmacy Solutions Announces Enhanced Offerings, Services and SavingsCitybizlist•Jul 30, 2018•SMP, Galen Partners
•
Galen Partners completes investment in SMP Pharmacy Solutions, a niche-focused, high-touch specialty pharmacyPM360 Magazine•Jul 19, 2018•SMP, Galen Partners
•
Galen Partners finally ends 10-year fundraising silence with $200m-targeting sixth fundAltAssets•Jan 05, 2018•Galen Partners
•
Ajinomoto Co. Inc. Acquires Cambrooke Therapeutics, Inc.Business Wire•Nov 10, 2017•http://ajinorthamerica.com, Cambrooke Therapeutics, Cambrooke Therapeutics, Ajinomoto and 4 others
•
Galen Partners Completes Majority Recapitalization of CDx DiagnosticsVCA Online•Jul 11, 2017•CDx Diagnostics, Galen Partners, White Oak Global Advisors
